Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
QuintilesIMS
Boehringer Ingelheim
Fuji
Julphar
Covington
Teva
McKinsey

Generated: June 17, 2018

DrugPatentWatch Database Preview

ETHMOZINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ethmozine patents expire, and what generic alternatives are available?

Ethmozine is a drug marketed by Shire and is included in one NDA.

The generic ingredient in ETHMOZINE is moricizine hydrochloride. Additional details are available on the moricizine hydrochloride profile page.
Summary for ETHMOZINE
Drug patent expirations by year for ETHMOZINE
Medical Subject Heading (MeSH) Categories for ETHMOZINE
Synonyms for ETHMOZINE
(10-(3-(4-Morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)carbamic acid, ethyl ester, monohydrochloride
29560-58-5
71OK3Z1ESP
AC1L1RZ0
AC1Q3EDS
ACM29560585
AKOS030506898
API0003427
Cambridge id 5229972
Carbamic acid, (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)-, ethyl ester, monohydrochloride
Carbamic acid, (10-(3-(4-morpholinyl)-l-oxopropyl)-10H-phenothiazin-2yl)-, ethyl ester, hydrochloride
Carbamic acid, N-(10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)-, ethyl ester, hydrochloride (1:1)
CAS-29560-58-5
CC-31001
CCG-221051
CHEBI:60937
CHEMBL1200334
D02087
DSSTox_CID_27766
DSSTox_GSID_47786
DSSTox_RID_82543
DTXSID1047786
E-313
E-350
EN 313
Ethmosine
Ethmozin
Ethmozine (TN)
Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate hydrochloride
Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate, hydrochloride
Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate hydrochloride
Ethyl ether of 10-(beta-morpholylpropionyl)phenthiazinecarbamino acid hydrochloride
ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate hydrochloride
ethyl-[10-(3-morpholin-4-ylpropanoyl)-10h-phenothiazin-2-yl]carbamathydrochlorid
Etmozin
FT-0630550
GAQAKFHSULJNAK-UHFFFAOYSA-N
HMS1571C04
LS-105268
MLS000080120
MLS000830274
MolPort-000-917-706
moracizine HCl
Moracizine hydrochloride
Moricizine HCl
MORICIZINE HYDROCHLORIDE
Moricizine hydrochloride (USP)
Moricizine hydrochloride [USP]
NCGC00016809-01
NCGC00016809-07
NCGC00180924-01
Opera_ID_267
Phenothiazine-2-carbamic acid, 10-(3-morpholinopropionyl)-, ethyl ester, hydrochloride
REGID_for_CID_34632
SCHEMBL41358
SMR000036736
SR-01000614327
SR-01000614327-4
Tox21_110622
Tox21_110622_1
UNII-71OK3Z1ESP
VA11324

US Patents and Regulatory Information for ETHMOZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-001 Jun 19, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-002 Jun 19, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-003 Jun 19, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for ETHMOZINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-001 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-003 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-002 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-001 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Chinese Patent Office
Baxter
QuintilesIMS
Express Scripts
Farmers Insurance
Covington
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.